Opening book details…
About this Medicine article
Safety, immunogenicity, and clinical outcomes in patients with Morquio A syndrome participating in 2 sequential open-label studies of elosulfase alfa enzyme replacement therapy (MOR-002/MOR-100), representing 5 years of treatment by Hendriksz, Christian ;Santra, Saikat ;Jones, Simon A. ;Geberhiwot, Tarekegn ;Jesaitis, Lynne ;Long, Brian ;Qi, Yulan ;Hawley, Sara M. ;Decker, Celeste is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Hendriksz, Christian ;Santra, Saikat ;Jones, Simon A. ;Geberhiwot, Tarekegn ;Jesaitis, Lynne ;Long, Brian ;Qi, Yulan ;Hawley, Sara M. ;Decker, Celeste
- Publisher
- Elsevier Science; Elsevier ; Elsevier Inc.; Elsevier BV (ISSN 1096-7192)
- Published
- 2018
- Language
- EN
- Field
- Medicine (Health Sciences)